A phase II study of gemcitabine (G), peghilated liposomal doxorubicin (PLD) and docetaxel (D) in locally advanced breast cancer (LABC): An interim analysis

Artioli, G. ; Bozza, F. ; Cartei, G. ; Zovato, S. ; Mencarelli, R. ; Zavagno, G. ; Michelotto, M.

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.10789-10789 [Periódico revisado por pares]

Sem texto completo